A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Sustained tuberculosis infection rates among adolescents were not lower following BCG revaccination vs placebo.

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases. Advances in biotechnology, ...

Turning thet tide against tuberculosis . As the world's deadliest infectious disease surges, GSK and partners are pioneering ...

Alzheimer’s disease, a devastating form of dementia, affects millions of people around the world. It slowly takes away memory ...

Here’s a look at Tuberculosis (also known as TB), an infection, caused by a bacterium called Mycobacterium tuberculosis, that usually affects the lungs. It can also infect other parts of the body ...